Exclusive: Musk’s Neuralink faces federal probe, employee backlash over animal tests

Exclusive: Musk’s Neuralink faces federal probe, employee backlash over animal tests

Dec 5 (Reuters) – Elon Musk’s Neuralink, a medical device company, is under federal investigation for potential animal-welfare violations amid internal staff complaints that its animal testing is being rushed, causing needless suffering and deaths, according to documents reviewed by Reuters and sources familiar with the investigation and company operations. Neuralink Corp is developing a … Read more

Amgen says experimental obesity drug has promising durability

Amgen says experimental obesity drug has promising durability

LOS ANGELES, Dec 3 (Reuters) – Amgen Inc’s (AMGN.O) experimental obesity drug demonstrated promising durability trends in an early trial, paving the way for a larger mid-stage study early next year, company officials said ahead of a data presentation on Saturday. The small Phase I trial found that patients maintained their weight loss for 70 … Read more

Judge blocks Indiana abortion ban on religious freedom grounds

Judge blocks Indiana abortion ban on religious freedom grounds

Dec 2 (Reuters) – A second Indiana judge on Friday blocked the state from enforcing its law banning most abortions after Jewish, Muslim and other non-Christian women challenged it in a lawsuit. Marion County Superior Court Judge Heather Welch issued a preliminary injunction against the Republican-backed law, which prohibits abortions with limited exceptions for rape, … Read more

Wall Street ends down sharply, hit by Apple and China worries

Wall Street ends down sharply, hit by Apple and China worries

Cyber Monday spending to hit $11.6 bln – report Crypto shares fall on BlockFi bankruptcy filing Biogen down after death in Alzheimer drug trial Indexes end: S&P 500 -1.54%, Nasdaq -1.58%, Dow -1.45% Nov 28 (Reuters) – U.S. stocks ended sharply lower on Monday after protests in major Chinese cities against strict COVID-19 policies sparked … Read more

Psychedelic mushrooms expand Jamaica tourism beyond sunshine and reggae

Psychedelic mushrooms expand Jamaica tourism beyond sunshine and reggae

TREASURE BEACH, Jamaica, Nov 24 (Reuters) – A new group of Jamaican resorts is promoting tourism that offers mystical experiences and stress relief through “magic mushrooms,” as the Caribbean nation seeks to develop a niche industry in natural psychedelics. While mushrooms containing the psychoactive compound psilocybin remain illegal in most parts of Europe and the … Read more

S&P closes at more than two-month high on retail, energy lift

S&P closes at more than two-month high on retail, energy lift

Best Buy up, sees smaller annual sales drop Dollar Tree drops on lower FY profit forecast Manchester United surges on sale report Dow up 1.18%, S&P 500 up 1.36%, Nasdaq up 1.36% NEW YORK, Nov 22 (Reuters) – U.S. stocks rallied on Tuesday, with the S&P 500 closing at its highest level in 2-1/2 months, … Read more

Britain’s NICE recommends against NHS use of 5 COVID treatments as not cost-effective

Britain’s NICE recommends against NHS use of 5 COVID treatments as not cost-effective

LONDON, Nov 16 (Reuters) – Britain’s agency that determines if medicines should be used in the National Health Service (NHS), has recommended stopping the use of five COVID-19 treatments, including Merck & Co’s (MRK.N)’s antiviral pill for high-risk patients, citing cost-effectiveness concerns. The review, conducted by the National Institute for Health and Care Excellence (NICE) … Read more

Roche’s Alzheimer’s drug fails to meet goal in long awaited trial

Roche’s Alzheimer’s drug fails to meet goal in long awaited trial

Trials show small benefit, but without statistical validity Roche’s setback leaves Biogen, Eisai as leaders in the field Onus on Roche CEO-designate to revive development fortunes Roche shares down 3.4%, development partner Morphosys down 29% Nov 14 (Reuters) – Roche’s (ROG.S) Alzheimer’s drug candidate could not be shown to slow dementia progression in two drug … Read more

Wall Street ends higher as investors eye U.S. midterms

Wall Street ends higher as investors eye U.S. midterms

Take-Two, Lyft slump on downbeat forecasts Amgen climbs on cholesterol drug data Indexes: S&P 500 +0.56%, Nasdaq +0.49%, Dow +1.02% Nov 8 (Reuters) – Wall Street ended higher on Tuesday during voting in midterm elections that will determine control of the U.S. Congress, with investors betting on a political stalemate that could prevent major policy … Read more

CVS, Walmart, Walgreens agree to pay $13.8 bln to settle U.S. opioid claims

CVS, Walmart, Walgreens agree to pay .8 bln to settle U.S. opioid claims

Nov 2 (Reuters) – CVS Health Corp (CVS.N), Walgreens Boots Alliance Inc (WBA.O) and Walmart Inc (WMT.N) have agreed to pay about $13.8 billion to resolve thousands of U.S. state, local and tribal government lawsuits accusing the pharmacy chains of mishandling opioid painkillers. CVS said Wednesday it had agreed to pay about $5 billion over … Read more